Showing codes Q0515 (Injection, sermorelin acetate, 1 microgram) — Q2047 (Injection, peginesatide, 0.1 mg (for esrd on dialysis))

Q0515 - Sermorelin acetate injection
Long description: Injection, sermorelin acetate, 1 microgram
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q0516 - Supply fee hiv prep oral 30
Long description: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days
Code added date: 20240102.
Code effective date: 20250101.
Pricing Indicator Code(s): 46 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q0517 - Supply fee hiv prep oral 60
Long description: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days
Code added date: 20240102.
Code effective date: 20250101.
Pricing Indicator Code(s): 46 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q0518 - Supply fee hiv prep oral 90
Long description: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days
Code added date: 20240102.
Code effective date: 20250101.
Pricing Indicator Code(s): 46 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q0519 - Supply fee hiv prep inj 30
Long description: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days
Code added date: 20240915.
Code effective date: 20250101.
Pricing Indicator Code(s): 46 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q0520 - Supply fee hiv prep inj 60
Long description: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days
Code added date: 20240915.
Code effective date: 20250101.
Pricing Indicator Code(s): 46 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q0521 - Supply fee hiv prep fda appr
Long description: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 46 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q1 - Routine clinical research
Long description: Routine clinical service provided in a clinical research study that is in an approved clinical research study
Code added date: 20080101.
Code effective date: 20080101.
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q1004 - Ntiol category 4
Long description: New technology intraocular lens category 4 as defined in federal register notice
Code added date: 19990701.
Code effective date: 20031001.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q1005 - Ntiol category 5
Long description: New technology intraocular lens category 5 as defined in federal register notice
Code added date: 19990701.
Code effective date: 20031001.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2 - Demo procedure, service
Long description: Demonstration procedure/service
Code added date: 19920101.
Code effective date: 20170101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2004 - Bladder calculi irrig sol
Long description: Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml
Code added date: 20000701.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2009 - Fosphenytoin inj pe
Long description: Injection, fosphenytoin, 50 mg phenytoin equivalent
Code added date: 20000701.
Code effective date: 20200101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2017 - Teniposide, 50 mg
Long description: Injection, teniposide, 50 mg
Code added date: 20000701.
Code effective date: 20260101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2026 - Radiesse injection
Long description: Injection, radiesse, 0.1 ml
Code added date: 20100701.
Code effective date: 20200101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2027 - Sculptra injection
Long description: Injection, sculptra, 0.1 ml
Code added date: 20100701.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2028 - Inj, sculptra, 0.5mg
Long description: Injection, sculptra, 0.5 mg
Code added date: 20140101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2033 - Influenza vaccine, (flublok)
Long description: Influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok)
Code added date: 20130701.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2034 - Agriflu vaccine
Long description: Influenza virus vaccine, split virus, for intramuscular use (agriflu)
Code added date: 20120701.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2035 - Afluria vacc, 3 yrs & >, im
Long description: Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)
Code added date: 20110101.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2036 - Flulaval vacc, 3 yrs & >, im
Long description: Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)
Code added date: 20110101.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2037 - Fluvirin vacc, 3 yrs & >, im
Long description: Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)
Code added date: 20110101.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2038 - Fluzone vacc, 3 yrs & >, im
Long description: Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
Code added date: 20110101.
Code effective date: 20140101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2039 - Influenza virus vaccine, nos
Long description: Influenza virus vaccine, not otherwise specified
Code added date: 20110101.
Code effective date: 20170101.
Pricing Indicator Code(s): 54 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2040 - Tisagenlecleucel car-pos t
Long description: Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
Code added date: 20180101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2041 - Axicabtagene ciloleucel car+
Long description: Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20180401.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2042 - Tisagenlecleucel car-pos t
Long description: Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2043 - Sipuleucel-t auto cd54+
Long description: Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
Code added date: 20110701.
Code effective date: 20110701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

Q2045 - Human fibrinogen conc inj
Long description: Injection, human fibrinogen concentrate, 1 mg
Code added date: 20120701.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2046 - Aflibercept injection
Long description: Injection, aflibercept, 1 mg
Code added date: 20120701.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

Q2047 - Peginesatide injection
Long description: Injection, peginesatide, 0.1 mg (for esrd on dialysis)
Code added date: 20120701.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF